Scarica l'app Stockscreener
44.08
0.36%
-0.16
Dopo l'orario di chiusura:
44.16
0.08
+0.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AA Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$44.24
Aprire:
$44.24
Volume 24 ore:
4.41M
Relative Volume:
0.83
Capitalizzazione di mercato:
$11.63B
Reddito:
$14.00B
Utile/perdita netta:
$1.26B
Rapporto P/E:
9.0422
EPS:
4.8749
Flusso di cassa netto:
$352.00M
1 W Prestazione:
+1.38%
1M Prestazione:
-18.52%
6M Prestazione:
-26.11%
1 anno Prestazione:
+42.93%
Intervallo 1D:
$43.50
$44.66
Intervallo di 1 settimana:
$43.41
$47.03
Portata 52W:
$28.11
$84.38
Agilent Technologies Inc Stock (AA) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
412-315-2900
Indirizzo
201 ISABELLA STREET, PITTSBURGH, PA
Compare AA vs TMO, DHR, IDXX, A, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AA
Agilent Technologies Inc
|
44.08 | 11.67B | 14.00B | 1.26B | 352.00M | 4.8749 |
TMO
Thermo Fisher Scientific Inc
|
559.53 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
556.20 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
137.89 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
258.03 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
Agilent Technologies Inc Stock (AA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-09 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2026-03-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2026-01-27 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2026-01-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2026-01-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-08 | Iniziato | Wells Fargo | Overweight |
| 2025-07-08 | Ripresa | Citigroup | Buy |
| 2025-05-15 | Downgrade | UBS | Buy → Neutral |
| 2025-04-08 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-10-23 | Aggiornamento | Argus | Hold → Buy |
| 2024-10-17 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2024-10-01 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-09-25 | Ripresa | JP Morgan | Neutral |
| 2024-09-04 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-08-12 | Aggiornamento | UBS | Sell → Buy |
| 2024-08-02 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2024-06-21 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-04-22 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-01-16 | Iniziato | UBS | Sell |
| 2023-12-07 | Iniziato | HSBC Securities | Hold |
| 2023-10-23 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-07-24 | Downgrade | Argus | Buy → Hold |
| 2023-07-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-07-11 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2023-06-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-05-11 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-05-08 | Iniziato | JP Morgan | Overweight |
| 2023-02-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-01-19 | Reiterato | B. Riley Securities | Neutral |
| 2022-12-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-07 | Iniziato | UBS | Neutral |
| 2022-09-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2022-09-16 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-21 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-08 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-11 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-11-17 | Iniziato | Wolfe Research | Outperform |
| 2021-11-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-10-05 | Reiterato | JP Morgan | Overweight |
| 2021-09-29 | Reiterato | Morgan Stanley | Overweight |
| 2021-09-15 | Aggiornamento | Argus | Hold → Buy |
| 2021-07-16 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-04-23 | Ripresa | JP Morgan | Overweight |
| 2021-03-24 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-03-17 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-03-03 | Aggiornamento | Goldman | Sell → Buy |
| 2020-09-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2020-03-24 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2020-03-04 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2020-01-17 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-12-17 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-13 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-11-12 | Reiterato | B. Riley FBR | Buy |
| 2019-11-07 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-10-21 | Downgrade | Gabelli & Co | Buy → Hold |
| 2019-09-26 | Reiterato | B. Riley FBR | Buy |
| 2019-09-23 | Downgrade | Goldman | Buy → Neutral |
| 2019-09-11 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-08-16 | Reiterato | BofA/Merrill | Neutral |
| 2019-07-19 | Downgrade | Argus | Buy → Hold |
| 2019-07-11 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-07-09 | Downgrade | Macquarie | Outperform → Neutral |
| 2019-04-22 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2019-04-03 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-04-02 | Downgrade | Credit Suisse | Outperform → Neutral |
Mostra tutto
Agilent Technologies Inc Borsa (AA) Ultime notizie
Agilent Technologies Inc (A): GF Score of 94 Signals Strong Outp - GuruFocus
Agilent Technologies price driven lower by important resistanceForecast today27-07-2026 - Economies.com
Precision Trading with Agilent Technologies Inc. (A) Risk Zones - Stock Traders Daily
Agilent Technologies, Inc. (A) Stock Analysis: Exploring A 14.97% Upside Potential - DirectorsTalk Interviews
Agilent Technologies stock steadies as investors weigh recent earnings and life-science demand trend - Ad-hoc-news.de
A|Agilent Technologies Inc|Price:138.570|Chg%:-1.185 - TradingKey
Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics? - Yahoo Finance UK
Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test - Yahoo Finance
Agilent Technologies Inc (A) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Agilent Technologies Inc (A) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Agilent Technologies Inc (A) Institutional Confidence - TradingKey
Agilent Technologies Inc (A) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
What to Expect From Agilent Technologies' Q3 2026 Earnings Report - inkl
A|Agilent Technologies Inc|Price:139.760|Chg%:+6.300 - TradingKey
Agilent Technologies Inc (A) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Agilent declares Q2 2026 distribution of R$ 0.44 per unit, payable July 28 - Bitget
A Look at Agilent Technologies Inc (A) After 4.7% Gain -- GF Val - GuruFocus
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Agilent Technologies (A) Secures EU Certification for Key Diagno - GuruFocus
Why Agilent Technologies Shares Are Rising Today - Quiver Quantitative
Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers - Moomoo
Agilent stock rises on EU approval for cancer diagnostic By Investing.com - Investing.com South Africa
Agilent stock rises on EU approval for cancer diagnostic - Investing.com
Agilent receives EU approval for ovarian cancer diagnostic test - Investing.com
Agilent receives EU approval for ovarian cancer diagnostic test By Investing.com - Investing.com South Africa
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma - Yahoo Finance
Agilent Technologies Inc (A) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Agilent BDR program executes 5-for-1 stock split on ratio adjustment - Bitget
A4881169 Bond Profile — Key Metrics - TradingView
Agilent Technologies (A) Stock Forecast & Analyst Ratings - Moomoo
Agilent stock holds near report levels as earnings metrics stay in view - Ad-hoc-news.de
Agilent Technologies (NYSE:A) Gains Fresh FDA Momentum - Kalkine Media
Agilent Technologies stock trades steady as life sciences demand supports revenue outlook - Ad-hoc-news.de
[Latest] Global Metal Stamping Market Size/Share Worth USD 412.6 Billion by 2035 at a 4.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Michael Buckner Joins Agilent Technologies as Chief Legal Officer - Medical Product Outsourcing
Agilent Technologies stock trades steadily as investors weigh recent earnings and life sciences dema - Ad-hoc-news.de
Agilent increases HALO X-ray Technologies stake - Airports International
HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited - marketscreener.com
Agilent Technologies (A) Stock Analysis: Unlocking a 21% Upside Potential with Robust Market Presence - DirectorsTalk Interviews
Agilent Technologies (A) Wells Fargo 20th Annual Healthcare Conference 2025 Summary - Quartr
Agilent Increases Its Investment in HALO X-ray Technologies - Morningstar
Agilent Technologies (A) Wins FDA Approval, Where Does Fair Value Sit Now? - Sahm
Agilent Technologies (A) Q2 2025 earnings summary - Quartr
Agilent Technologies (A) Q1 2026 earnings summary - Quartr
Agilent Technologies stock trades steady as recent earnings and life-science demand underpin valuati - Ad-hoc-news.de
Agilent Technologies (A) Citi Annual Global Healthcare Conference 2025 Summary - Quartr
Agilent Technologies (A) Proxy Filing Summary - Quartr
Agilent Technologies (A) Q4 2025 earnings summary - Quartr
Agilent Technologies stock holds support as results stay in focus - Ad-hoc-news.de
Agilent 1260 Infinity II LC by Agilent Technologies Inc.mid-range workhorse for routine labs - Ad-hoc-news.de
Agilent Technologies Inc (A) Stock Down 3.4% -- Now Undervalued? GF Score: 93/100 - GuruFocus
Agilent Technologies Inc Azioni (AA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
2.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):